Important OptumRx updates to support providers, clinical staff and patients through COVID-19.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
June 15, 2020 - The drug shortage of Teva’s amoxapine is ongoing. Amoxapine has been unavailable for at least 90 days due to manufacturing delays from capacity constraints.
Return to publications